David Green
Finanzdirektor/CFO bei SEASTAR MEDICAL HOLDING CORPORATION
Vermögen: 97 808 $ am 30.04.2024
Profil
David A.
Green's current job is Chief Financial Officer at Seastar Medical Holding Corp.
Former jobs include Managing Director-Investment Banking at Duff & Phelps LLC, Chief Financial Officer & Treasurer at SJW Group, Chief Financial Officer, Treasurer & VP at Specialized Health Products International, Inc., Member-Center for Strategic Transactions at Ernst & Young LLP, Chief Financial Officer at Q Therapeutics, Inc., Chief Financial Officer at Catheter Connections, Inc., Chief Accounting Officer at Intarcia Therapeutics, Inc., Chief Financial Officer & Treasurer at San Jose Water Co., Chief Financial Officer & Treasurer at SJW Land Co., Chief Financial Officer & Treasurer at The Texas Water Co., Chief Financial Officer & Treasurer at Texas Water Alliance Ltd., Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc., Chief Financial Officer at Blackswan Vascular, Inc., Chief Financial Officer at Prolacta Biosciences, Inc., and Chief Financial Officer at Lamamed Solutions, Inc. Education history includes an MBA from Rochester Christian University and an undergraduate degree from The State University of New York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2024 | 202 500 ( 0,31% ) | 97 808 $ | 30.04.2024 |
Aktive Positionen von David Green
| Unternehmen | Position | Beginn |
|---|---|---|
| SEASTAR MEDICAL HOLDING CORPORATION | Finanzdirektor/CFO | 10.01.2024 |
Ehemalige bekannte Positionen von David Green
| Unternehmen | Position | Ende |
|---|---|---|
| AYTU BIOPHARMA, INC. | Finanzdirektor/CFO | 01.05.2022 |
| AYTU BIOPHARMA, INC. | Finanzdirektor/CFO | 31.03.2021 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Comptroller/Controller/Auditor | 01.02.2017 |
Ausbildung von David Green
| Rochester Christian University | Masters Business Admin |
| The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SJW GROUP | Utilities |
| AYTU BIOPHARMA, INC. | Health Technology |
| SEASTAR MEDICAL HOLDING CORPORATION | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Specialized Health Products International, Inc.
 Specialized Health Products International, Inc. Medical SpecialtiesHealth Technology Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT. | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
San Jose Water Co.
 San Jose Water Co. Water UtilitiesUtilities San Jose Water Co. provides water utility services. It also provides water audits and conservation devices such as low-flow showerheads and faucet aerators. The company was founded in 1866 and is headquartered in San Jose, CA. | Utilities |
SJW Land Co.
 SJW Land Co. Real Estate DevelopmentFinance SJW Land Co. engages in the real estate development. It owns commercial buildings, undeveloped land, and a majority interest in a real estate partnership. The company was founded in 1985 and is headquartered in San Jose, CA. | Finance |
Texas Water Alliance Ltd.
 Texas Water Alliance Ltd. Water UtilitiesUtilities Texas Water Alliance Ltd. supplies and distributes water. The company is headquartered in Dallas, TX. | Utilities |
Duff & Phelps LLC
 Duff & Phelps LLC Investment ManagersFinance Duff & Phelps LLC provides financial advising and investment banking services. It's consulting and investment banking services include financial reporting and tax valuation, fixed asset and real estate consulting, M&A advisory, fairness and solvency opinions, ESOP and ERISA advisory services, legal business solutions and dispute consulting. The company was founded in 1932 and is headquartered in Chicago, IL. | Finance |
The Texas Water Co.
 The Texas Water Co. Water UtilitiesUtilities The Texas Water Co. engages in the supply of water services. Its service area surrounds Canyon Lake and includes approximately 250 square miles within Comal County and southern Blanco County. The company was founded in 1994 and is headquartered in New Braunfels, TX. | Utilities |
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |